1. Volume 156, Pages 163-167 (August 2017)
Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation 
Tapio Hellman, Tuomas Kiviniemi, Ilpo Nuotio, Tuija Vasankari, Juha Hartikainen, Gregory Y.H. Lip, K.E. Juhani Airaksinen 
Thrombosis Research 
Volume 156, Pages (August 2017)
DOI: /j.thromres
Copyright © 2017 Elsevier Ltd Terms and Conditions

2. Fig. 1 Flow chart illustrating patient selection in the study.
AF=atrial fibrillation; ECV=elective cardioversion.
Thrombosis Research  , DOI: ( /j.thromres )
Copyright © 2017 Elsevier Ltd Terms and Conditions

3. Fig. 2
Incidence of thromboembolic events in patients with high (≥2.5) therapeutic INRs (full color) compared to those with low (2.0–2.4) therapeutic INRs (no color) at elective cardioversion (ECV) (Panel A), and in patients with therapeutic (≥2.0) vs. subtherapeutic (<2.0) INRs within 21days after ECV (Panel B).
Thrombosis Research  , DOI: ( /j.thromres )
Copyright © 2017 Elsevier Ltd Terms and Conditions